← Back to Search

Cohort A for Interstitial Lung Disease (ASCENT Trial)

N/A
Recruiting
Research Sponsored by Liquidia Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline until the end of the study, approximately 2.5 years, june 2026
Awards & highlights

ASCENT Trial Summary

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 & 3 PH.

Eligible Conditions
  • Interstitial Lung Disease
  • Pulmonary Hypertension

ASCENT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline until the end of the study, approximately 2.5 years, june 2026
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline until the end of the study, approximately 2.5 years, june 2026 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with treatment-emergent drug/device-related adverse events and Serious Adverse Events (SAEs)

ASCENT Trial Design

1Treatment groups
Experimental Treatment
Group I: Cohort AExperimental Treatment1 Intervention
PH-ILD

Find a Location

Who is running the clinical trial?

Liquidia Technologies, Inc.Lead Sponsor
6 Previous Clinical Trials
469 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
2023. "An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06129240.
All > Phoenix > Indianapolis
~40 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top